Close

Analyst Ratings for Axovant Gene Therapies (AXGT)

AXGT Rating Summary

  |   Expand Research on AXGT
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/17/2020 Cantor Fitzgerald Kristen Kluska New Coverage Overweight
(N/A)
11.00
(N/A)
3.45
(2.10)
-39.13% Details
8/12/2019 Baird Brian Skorney Upgrade Outperform
(Neutral)
13.00
(16.00)
6.61
(2.10)
-68.23% Details
Like AXGT Ratings? Also take a look at

AXGT Ratings News